| Data | Ora | Fonte | Titolo | Simbolo | Compagnia |
| 02/09/2011 | 12:00 | Business Wire | SuperGen to Present at Rodman & Renshaw Annual Healthcare Conference as Astex Pharmaceuticals, Inc. on September 12th | NASDAQ:SUPG | Supergen, Inc. (MM) |
| 02/09/2011 | 12:00 | Business Wire | SuperGen, Inc. to Change Name and Stock Ticker Symbol | NASDAQ:SUPG | Supergen, Inc. (MM) |
| 09/08/2011 | 22:07 | Edgar (US Regulatory) | Quarterly Report (10-Q) | NASDAQ:SUPG | Supergen, Inc. (MM) |
| 03/08/2011 | 13:45 | Business Wire | SuperGen Reports 2011 Second Quarter Financial Results | NASDAQ:SUPG | Supergen, Inc. (MM) |
| 26/07/2011 | 20:20 | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:SUPG | Supergen, Inc. (MM) |
| 25/07/2011 | 22:05 | Edgar (US Regulatory) | Securities Registration: Employee Benefit Plan (S-8) | NASDAQ:SUPG | Supergen, Inc. (MM) |
| 23/07/2011 | 01:56 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:SUPG | Supergen, Inc. (MM) |
| 23/07/2011 | 01:38 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NASDAQ:SUPG | Supergen, Inc. (MM) |
| 22/07/2011 | 12:00 | Business Wire | SuperGen to Announce 2011 Second Quarter Financial Results on August 3, 2011 | NASDAQ:SUPG | Supergen, Inc. (MM) |
| 20/07/2011 | 18:30 | Business Wire | SuperGen Completes Acquisition of Astex Therapeutics | NASDAQ:SUPG | Supergen, Inc. (MM) |
| 13/07/2011 | 14:00 | Business Wire | FDA Accepts DACOGEN® (Decitabine) sNDA Submission in Acute Myeloid Leukemia | NASDAQ:SUPG | Supergen, Inc. (MM) |
| 28/06/2011 | 22:27 | Business Wire | SuperGen President & CEO Elected to BIO Board of Directors | NASDAQ:SUPG | Supergen, Inc. (MM) |
| 17/06/2011 | 00:00 | Business Wire | SuperGen Stockholders Approve Stock Issuance In Connection with the Proposed Acquisition of Astex Therapeutics Limited | NASDAQ:SUPG | Supergen, Inc. (MM) |
| 06/06/2011 | 20:50 | PR Newswire (US) | SuperGen, Inc. Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com | NASDAQ:SUPG | Supergen, Inc. (MM) |
| 06/06/2011 | 18:00 | Business Wire | Eisai & Janssen Announce the Presentation of DACOGEN® (decitabine) Data at ASCO from a Phase III Study in Patients with Acut... | NASDAQ:SUPG | Supergen, Inc. (MM) |
| 31/05/2011 | 18:57 | PR Newswire (US) | Public Company CEOs Present Live, Online at June 2nd RetailInvestorConferences.com Event | NASDAQ:SUPG | Supergen, Inc. (MM) |
| 26/05/2011 | 21:00 | PR Newswire (US) | SuperGen, Inc. to Present Live, Online at RetailInvestorConferences.com on June 2nd | NASDAQ:SUPG | Supergen, Inc. (MM) |
| 25/05/2011 | 22:56 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (DEFA14A) | NASDAQ:SUPG | Supergen, Inc. (MM) |
| 16/05/2011 | 14:00 | Business Wire | SuperGen to Present at BioEquity Europe on May 23rd & 24th | NASDAQ:SUPG | Supergen, Inc. (MM) |
| 10/05/2011 | 12:00 | Business Wire | SuperGen to Present at Noble Financial Capital Markets Equity Conference on May 17th | NASDAQ:SUPG | Supergen, Inc. (MM) |
| 02/05/2011 | 23:24 | Edgar (US Regulatory) | Proxy Statement - Merger or Acquistion (definitive) (DEFM14A) | NASDAQ:SUPG | Supergen, Inc. (MM) |
| 27/04/2011 | 22:00 | Business Wire | SuperGen Reports 2011 First Quarter Financial Results | NASDAQ:SUPG | Supergen, Inc. (MM) |
| 22/04/2011 | 23:29 | Edgar (US Regulatory) | Proxy Statement - Merger or Acquistion (preliminary) (PREM14A) | NASDAQ:SUPG | Supergen, Inc. (MM) |
| 20/04/2011 | 12:00 | Business Wire | SuperGen to Announce 2011 First Quarter Financial Results on April 27, 2011 | NASDAQ:SUPG | Supergen, Inc. (MM) |
| 08/04/2011 | 12:00 | Business Wire | SuperGen to Present at Future Leaders in the Biotech Industry on April 15th | NASDAQ:SUPG | Supergen, Inc. (MM) |
| 07/04/2011 | 03:56 | Business Wire | SuperGen and Astex Therapeutics Enter Definitive Merger Agreement | NASDAQ:SUPG | Supergen, Inc. (MM) |
| 31/03/2011 | 12:00 | Business Wire | SuperGen to Webcast 5th Annual Investor & Analyst Day on April 12, 2011 | NASDAQ:SUPG | Supergen, Inc. (MM) |
| 31/03/2011 | 12:00 | Business Wire | SuperGen PIM Kinase Presentations at AACR | NASDAQ:SUPG | Supergen, Inc. (MM) |
| 09/03/2011 | 22:13 | Edgar (US Regulatory) | Annual Report (10-K) | NASDAQ:SUPG | Supergen, Inc. (MM) |
| 08/03/2011 | 12:00 | Business Wire | SuperGen to Present at ROTH Annual OC Growth Stock Conference on March 14th | NASDAQ:SUPG | Supergen, Inc. (MM) |